GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Definitive Healthcare Corp (NAS:DH) » Definitions » Altman Z2-Score

Definitive Healthcare (Definitive Healthcare) Altman Z2-Score : 0.74 (As of May. 28, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Definitive Healthcare Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Definitive Healthcare has a Altman Z2-Score of 0.74, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Definitive Healthcare's Altman Z2-Score or its related term are showing as below:

DH' s Altman Z2-Score Range Over the Past 10 Years
Min: 0.74   Med: 2.15   Max: 2.33
Current: 0.74

During the past 5 years, Definitive Healthcare's highest Altman Z2-Score was 2.33. The lowest was 0.74. And the median was 2.15.


Definitive Healthcare Altman Z2-Score Historical Data

The historical data trend for Definitive Healthcare's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Definitive Healthcare Altman Z2-Score Chart

Definitive Healthcare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z2-Score
- 2.15 2.33 2.26 0.76

Definitive Healthcare Quarterly Data
Jul19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.31 2.30 0.83 0.76 0.74

Competitive Comparison of Definitive Healthcare's Altman Z2-Score

For the Health Information Services subindustry, Definitive Healthcare's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Definitive Healthcare's Altman Z2-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Definitive Healthcare's Altman Z2-Score falls into.



Definitive Healthcare Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Definitive Healthcare's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.1181+3.26*-0.1309+6.72*-0.16+1.05*1.3986
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2024:
Total Assets was $1,810.1 Mil.
Total Current Assets was $378.7 Mil.
Total Current Liabilities was $165.0 Mil.
Retained Earnings was $-237.0 Mil.
Pre-Tax Income was -13.498 + -12.187 + -266.222 + -13.089 = $-305.0 Mil.
Interest Expense was -3.816 + -3.899 + -3.897 + -3.793 = $-15.4 Mil.
Total Liabilities was $615.1 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(378.717 - 164.98)/1810.145
=0.1181

X2=Retained Earnings/Total Assets
=-236.968/1810.145
=-0.1309

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-304.996 - -15.405)/1810.145
=-0.16

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(860.29 - 0)/615.114
=1.3986

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Definitive Healthcare has a Altman Z2-Score of 0.74 indicating it is in Distress Zones.


Definitive Healthcare  (NAS:DH) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Definitive Healthcare Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of Definitive Healthcare's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Definitive Healthcare (Definitive Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
492 Old Connecticut Path, Suite 401, Framingham, MA, USA, 01701
Definitive Healthcare Corp is a leading provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of its revenue from the United States.
Executives
Carrie Lazorchak officer: Chief Revenue Officer C/O DEFINITIVE HEALTHCARE CORP., 492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM MA 01701
Scott G Stephenson director C/O VERISK ANALYTICS, INC., 545 WASHINGTON BOULEVARD, JERSEY CITY NJ 07310-1686
Sea Vii Management, Llc director, 10 percent owner ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent International Gp, Llc director, 10 percent owner 800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199
Spectrum Vii Investment Managers' Fund, L.p. director, 10 percent owner ONE INTERNATIONAL PLACE, 35TH FLOOR, BOSTON MA 02110
Jason Ronald Krantz director, 10 percent owner, officer: Chief Executive Officer C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Jonathan Maack officer: President C/O DEFINITIVE HEALTHCARE CORP., 550 COCHITUATE RD, FRAMINGHAM MA 01701
Sastry Chilukuri director 5 BUDDY LANE, MORRISTOWN NJ 07960
David Randall Winn director 7900 GLADES ROAD, SUITE 540, BOCA RATON FL 33434
Jeffrey Charles Haywood director, 10 percent owner C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Richard Douglas Booth officer: Chief Financial Officer 200 CLARENDON STREET, T-9, BOSTON MA 02116
Kathleen A Winters director 101 COLUMBIA ROAD, MORRISTOWN NJ 07960
Spectrum Vii Co-investment Fund, L.p. director, 10 percent owner ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent Global Technology-c Limited Partnership director, 10 percent owner PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069
Advent Global Technology-d Limited Partnership director, 10 percent owner PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069